
Submitter(s): Dennis P. O'Malley, Michele Hibbard, Jess Savala, Shi-Ping Jiang, Richard McMasters, Wayne Chen, Changjun Yue, Robert Stroup, Hector Zepeda. Clinical history CONTINUATION/ADDITIONAL INFORMATION FOR SUBMISSION 750190 66 year old man presented with history of weakness and fatigue. Had DVT in past. Physical examination revealed splenomegaly, 2-3 cm below the margin of the ribs. Laboratory studies at presentation included: LAP: 10 (low) (NL range 25-130) LDH: 655 (100-250) Uric Acid: 9.8 (2.4-8.2) B12: >2000 (211-911) Folate: 6.2 (NL >5.4). Details of gross/microscopic pathology: Peripheral blood: Leukocytosis composed of predominantly neutrophils with a left shift in maturation. Blasts not significantly increased. Some increase in basophils. Bone marrow aspirate: Markedly increased granulocytes and precursors, without significant increase in blasts. Increased eosinophils and precursors. Occasional dwarf megakaryocytes. Clot section/core biopsy: Hypercellular with increased myeloid elements. Dwarf megakaryocytes are frequent. Immature/blast forms do not appear increased. Immunophenotype (flow cytometry/immunohistochemistry): Bone marrow flow: Blasts <1%; Lymphocytes 1%; Monocytes <1%; plasma cells <1% Myeloid 97% Myeloid phenotype typical except for increased expression of CD56 on myeloid elements. Cytogenetics: t(9;17;22)(p24;p11.1;q11.2) FISH for BCR/ABL - negative, but extra copy of BCR in some cells. Molecular analysis: Negative for JAK2 mutation. Interesting feature(s) of submitted case: Rare variant of CML which has appears to have a fusion of BCR and JAK2 (not JAK2 mutation). This has been reported once before in Greisinger et al. Genes Chrom Cancer 205;44. The index case was not reponsive to Gleevec. Proposed diagnosis: Chronic myelogenous leukemia with variant translocation t(9;17;22)(p24;p11.1;q11.2). Presumed fusion of BCR and JAK2. Panel diagnosis: agree with proposed diagnosis Comments: Images:
Back to Top Back to Cases by Session Back to Cases by Contact Submitter |